Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control
- PMID: 25849783
- PMCID: PMC4330943
- DOI: 10.1186/s12933-015-0187-2
Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control
Abstract
Background: Both non-alcoholic fatty liver disease (NAFLD) and Type 2 diabetes increase the risk of developing cardiovascular disease. The metabolic processes underlying NAFLD and Type 2 diabetes are part of an integrated mechanism but little is known about how these conditions may differentially affect the heart. We compared the impact of NAFLD and Type 2 diabetes on cardiac structure, function and metabolism.
Methods: 19 adults with Type 2 diabetes (62 ± 8 years), 19 adults with NAFLD (54 ± 15 years) and 19 healthy controls (56 ± 14 years) underwent assessment of cardiac structure, function and metabolism using high resolution magnetic resonance imaging, tagging and spectroscopy at 3.0 T.
Results: Adults with NAFLD and Type 2 diabetes demonstrate concentric remodelling with an elevated eccentricity ratio compared to controls (1.05 ± 0.3 vs. 1.12 ± 0.2 vs. 0.89 ± 0.2 g/ml; p < 0.05). Despite this, only the Type 2 diabetes group demonstrate significant systolic and diastolic dysfunction evidenced by a reduced stroke index (31 ± 7vs. controls, 38 ± 10, p < 0.05 ml/m2) and reduced E/A (0.9 ± 0.4 vs. controls, 1.9 ± 1.4, p < 0.05) respectively. The torsion to shortening ratio was higher in Type 2 diabetes compared to NAFLD (0.58 ± 0.16 vs. 0.44 ± 0.13; p < 0.05). Significant associations were observed between fasting blood glucose/HbA1c and diastolic parameters as well as the torsion to shortening ratio (all p < 0.05). Phosphocreatine/adenosine triphosphate ratio was not altered in NAFLD or Type 2 diabetes compared to controls.
Conclusions: Changes in cardiac structure are evident in adults with Type 2 diabetes and NAFLD without overt cardiac disease and without changes in cardiac energy metabolism. Only the Type 2 diabetes group display diastolic and subendocardial dysfunction and glycemic control may be a key mediator of these cardiac changes. Therapies should be explored to target these preclinical cardiac changes to modify cardiovascular risk associated with Type 2 diabetes and NAFLD.
Figures
Similar articles
-
Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.J Clin Endocrinol Metab. 2020 May 1;105(5):dgaa112. doi: 10.1210/clinem/dgaa112. J Clin Endocrinol Metab. 2020. PMID: 32144419
-
The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.Metab Syndr Relat Disord. 2019 Oct;17(8):389-396. doi: 10.1089/met.2019.0038. Epub 2019 Jul 15. Metab Syndr Relat Disord. 2019. PMID: 31305201 Review.
-
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G91-G96. doi: 10.1152/ajpgi.00216.2017. Epub 2017 Sep 28. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 28971838
-
The role of incretin hormones and glucagon in patients with liver disease.Dan Med J. 2017 May;64(5):B5363. Dan Med J. 2017. PMID: 28552096 Review.
-
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease.J Hepatol. 2013 Apr;58(4):757-62. doi: 10.1016/j.jhep.2012.11.015. Epub 2012 Nov 22. J Hepatol. 2013. PMID: 23178979
Cited by
-
The effects of long-term changes in metabolic parameters on cardiac remodeling and dysfunction.Hypertens Res. 2024 Mar;47(3):816-818. doi: 10.1038/s41440-023-01555-w. Epub 2023 Dec 22. Hypertens Res. 2024. PMID: 38135847 No abstract available.
-
Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292. Int J Mol Sci. 2023. PMID: 37762592 Free PMC article. Review.
-
Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice.Front Neurosci. 2023 Mar 9;17:1061485. doi: 10.3389/fnins.2023.1061485. eCollection 2023. Front Neurosci. 2023. PMID: 36968490 Free PMC article.
-
Contribution of Modern Echocardiographic Techniques in the Detection of Subclinical Heart Dysfunction in Young Adults with Non-Alcoholic Fatty Liver Disease.Curr Health Sci J. 2021 Apr-Jun;47(2):275-283. doi: 10.12865/CHSJ.47.02.19. Epub 2021 Jun 30. Curr Health Sci J. 2021. PMID: 34765249 Free PMC article.
-
Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population.J Clin Med. 2021 Aug 27;10(17):3851. doi: 10.3390/jcm10173851. J Clin Med. 2021. PMID: 34501302 Free PMC article.
References
-
- International Diabetes Federation . IDF diabetes atlas. 6. Brussels, Belgium: International Diabetes Federation; 2013. - PubMed
-
- Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31. doi: 10.1053/j.gastro.2010.09.038. - DOI - PubMed
-
- Sattar N, McConnachie A, Ford I, Gaw A, Cleland SJ, Forouhi NG, et al. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes. 2007;56:984–91. doi: 10.2337/db06-1256. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical